<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01382420</url>
  </required_header>
  <id_info>
    <org_study_id>2011-03-034</org_study_id>
    <nct_id>NCT01382420</nct_id>
  </id_info>
  <brief_title>Long-term Beneficial Metabolic Effects of Adrenalectomy in Subclinical Cushing's Syndrome of Adrenal Incidentaloma</brief_title>
  <official_title>Long-term Effects of Adrenalectomy on Metabolic Syndrome, Glucose Metabolism, Lipid Metabolism, and Bone Metabolism in Subclinical Cushing's Syndrome of Adrenal Incidentaloma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Samsung Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Asan Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Severance Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Konkuk University Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Samsung Medical Center</source>
  <brief_summary>
    <textblock>
      Objective:

      To determine the metabolic effects of the adrenalectomy in subclinical Cushing's syndrome of
      adrenal incidentaloma.

      Methods:

      234 subclinical cushing syndrome and adrenal incidentaloma will be randomly assigned into two
      groups(e.g adrenalectomy group and conservative treatment group).
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>May 2011</start_date>
  <completion_date type="Anticipated">May 2018</completion_date>
  <primary_completion_date type="Anticipated">May 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change of lipid profile between two groups</measure>
    <time_frame>4 Year</time_frame>
    <description>lipid profile with LDL,apo B</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of obesity between two groups</measure>
    <time_frame>4Year</time_frame>
    <description>measurement of body weight, height</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">234</enrollment>
  <condition>Cushing Syndrome</condition>
  <arm_group>
    <arm_group_label>Adrenalectomy group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patients who undergo adrenalectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>patients who receive conservative treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>surgery</intervention_name>
    <description>adrenalectomy</description>
    <arm_group_label>Adrenalectomy group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with both unilateral adrenal incidentaloma and hypercortisolism

          -  definition of hypercortisolism

               -  overnight dexamethasone suppression test, serum cortisol&gt;1.8ug/dL

               -  24hr urine cortisol &gt; upper reference limit

        Exclusion Criteria:

          -  patients who took medication influencing cortisol secretion

          -  patients with definite clinical feature of cushing syndrome

               -  moon face

               -  abdominal striae

               -  skin or proximal muscle atrophy

          -  metabolic syndrome, hyperthyroidism, hyperparathyroidism, chronic renal failure,
             rheumatic disease, hematologic disease

          -  patients who took following medication

               -  insulin

               -  oral hypoglycemic agent

               -  thyroid hormone

               -  anti-hyperlipidemic drug

               -  sex hormone

          -  patients who taking steroid hormone or who took steroid hormone more than 2 weeks
             within 1 year

          -  psychiatric disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jae Hyeon Kim</last_name>
    <role>Study Director</role>
    <affiliation>Samsung Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jung-Min Koh</last_name>
    <role>Study Chair</role>
    <affiliation>M.D, Ph.D</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kee-Ho Song</last_name>
    <role>Principal Investigator</role>
    <affiliation>M.D, Ph.D.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yumie Rhee</last_name>
    <role>Principal Investigator</role>
    <affiliation>M.D, Ph.D.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jae Hyeon Kim, M.D, Ph.D.</last_name>
    <phone>82-2-3410-1580</phone>
    <email>jaehyeonmd.kim@samsung.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Seo Young Sohn</last_name>
    <phone>82-2-3410-1582</phone>
    <email>seoyoung.sohn@samsung.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Samsung Medical Center</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>November 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 30, 2011</study_first_submitted>
  <study_first_submitted_qc>June 23, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 27, 2011</study_first_posted>
  <last_update_submitted>November 16, 2015</last_update_submitted>
  <last_update_submitted_qc>November 16, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 17, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Samsung Medical Center</investigator_affiliation>
    <investigator_full_name>Jae Hyeon Kim</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>subclinical cushing syndrome</keyword>
  <keyword>hypercortisolism</keyword>
  <keyword>adrenal incidentaloma</keyword>
  <keyword>adrenalectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Cushing Syndrome</mesh_term>
    <mesh_term>Adrenocortical Adenoma</mesh_term>
    <mesh_term>Adrenal Gland Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epinephrine</mesh_term>
    <mesh_term>Racepinephrine</mesh_term>
    <mesh_term>Epinephryl borate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

